microdosing semaglutide for weight loss Our Clinic's Chart: Real Doses from 200+ Patients (Starting at 0.05 mg) People are 'microdosing' weight-loss drugs—a

doi: 10.3389/fphar.2024.1364110 Received 01 January 2024 Accepted 02 May 2024 Published 27 May 2024 Volume 15 - 2024 Edited by Zoltn S

Significant Weight Loss: Users can lose an average of 15-20% of their body weight, promoting overall health

Phentermine, an FDA-approved appetite suppressant since 1959, works through central nervous system stimulation, while tirzepatide (Zepbound, Mounjaro), approved in 2023 for obesity, operates through dual GIP/GLP-1 receptor pathways

However, its not recommended for individuals with a personal or family history of certain health conditions, and it may interact with certain medications

The guide on water to mix with peptides covers this in depth, but here is what you need to know specifically for semaglutide